業(yè)執(zhí)照.jpg)
濱蒿內(nèi)酯
分析標(biāo)準(zhǔn)品,HPLC≥98%
Scoparone
CAS號(hào)：120-08-1
分子式：C11H10O4
分子量：206.19
MDL：MFCD00006871
別名：香豆 素二甲醚; 二甲氧香豆 素; 6,7-二甲基七葉亭; 東喘寧; 蒿屬香豆 素
貨號(hào) | 規(guī)格/參數(shù)/品牌 | 價(jià)格 | 貨期 |
YJ-B20110-20mg | 分析標(biāo)準(zhǔn)品,HPLC≥98% | ￥285.00 | 現(xiàn)貨 |
YJ-B20110-200mg | 分析標(biāo)準(zhǔn)品,HPLC≥98% | ￥1100.00 | 現(xiàn)貨 |
A10289-20mg | 分析標(biāo)準(zhǔn)品,含量98.8%，可溯源 | ￥330.00 | 現(xiàn)貨 |
產(chǎn)品介紹
熔點(diǎn)：145℃
沸點(diǎn)：369.2℃ at 760 mmHg
外觀：白色或黃色絨毛狀結(jié)晶
溶解性：易溶于乙醇、丙tong、氯仿， 難溶于水，不溶于石油醚。
儲(chǔ)存條件：2-8℃
注意：部分產(chǎn)品我司僅能提供部分信息，我司不保證所提供信息的權(quán) 威性，僅供客戶(hù)參考交流研究之用。
參考文獻(xiàn)(16篇)
16. [IF=4.2] Ping Huang et al."Scoparone alleviates nonalcoholic fatty liver disease by modulating the PPARα signaling pathway."EUROPEAN JOURNAL OF PHARMACOLOGY.2024 Dec;984:177033
15. [IF=5] Luyao Liu et al."Targeted discovery of gut microbiome-remodeling compounds for the treatment of systemic inflammatory response syndrome."mSystems.
14. [IF=6.4] Yanting Yang et al."Identification of candidate genes involved in scoparone biosynthesis in citrus fruit through transcriptome analysis stimulated by salicylic acid."POSTHARVEST BIOLOGY AND TECHNOLOGY.2024 Dec;218:113132
13. [IF=2.2] Yang Mengke et al."Feeding-induced plant metabolite responses to a phoretic gall mite, its carrier psyllid and both, after detachment."EXPERIMENTAL AND APPLIED ACAROLOGY.2023 Nov;91(3):381-403
12. [IF=4.9] Zhang Min et al."Discovery and evaluation of active compounds from Xuanfei Baidu formula against COVID-19 via SARS-CoV-2 Mpro."Chinese Medicine.2023 Dec;18(1):1-14
11. [IF=6.656] Yanchao Xing et al."Cytochrome P450-mediated herb-drug interaction (HDI) of Polygonum multiflorum Thunb. based on pharmacokinetic studies and in vitro inhibition assays."PHYTOMEDICINE.2023 Feb;:154710
10. [IF=2.586] Mailing Zou et al."Profiling aromatic constituents of Chimonanthus nitens Oliv. leaf granule using mass spectrometry."RAPID COMMUNICATIONS IN MASS SPECTROMETRY.2023 Jan;:e9481
9. [IF=6.055] Xiaoyan Huang et al."Effects of scoparone on non-alcoholic fatty liver disease revealed by RNA sequencing."Frontiers in Endocrinology.2022; 13: 1004284
8. [IF=7.419] Min Wei et al."The effects of scoparone on alcohol and high-fat diet-induced liver injury revealed by RNA sequencing."BIOMEDICINE & PHARMACOTHERAPY.2022 Nov;155:113770
7. [IF=3.475] Jinxiang Luo et al."Photodegradation of the pure and formulated scoparone in liquid solutions: Kinetics and mechanism."ENVIRONMENTAL TECHNOLOGY
6. [IF=2.408] Ying-Hui He et al."Antifungal Activity and Action Mechanism Study of Coumarins from Cnidium monnieri Fruit and Structurally Related Compounds."Chemistry & Biodiversity. 2021 Oct 27
5. [IF=4.411] Liang Yang et al."New Insights into the Antibacterial Activity of Hydroxycoumarins against Ralstonia solanacearum."Molecules. 2016 Apr;21(4):468
4. 何薇,程歡,譚羅超.濱蒿內(nèi)酯抗動(dòng)脈粥樣硬化的作用及機(jī)制探討[J].中國(guó)煤炭工業(yè)醫(yī)學(xué)雜志,2020,23(06):561-567.
3. 方悅, 黃學(xué)娟, 尤心怡,等. 蟛蜞菊內(nèi)酯大鼠血漿蛋白結(jié)合率的測(cè)定[J]. 藥學(xué)與臨床研究, 2015(03):246-248.
2. 徐劍, 林莉, 王翔. 濱蒿內(nèi)酯在抗動(dòng)脈粥樣硬化中的作用及機(jī)制[J]. 現(xiàn)代實(shí)用醫(yī)學(xué), 2020, 032(001):25-28,封2.
1. 覃小花 盧秀玉. 化濕利膽片的定性質(zhì)量控制方法和利膽作用研究[J]. 海峽藥學(xué) 2019 v.31;No.231(04):71-73.
從2011年開(kāi)始我們致力于在生命科學(xué)領(lǐng)域、生物醫(yī)學(xué)實(shí)驗(yàn)技術(shù)及論文潤(rùn)色服務(wù)，協(xié)助客戶(hù)各類(lèi)實(shí)驗(yàn)服務(wù)及論文潤(rùn)色十余年，是客戶(hù)您值得信賴(lài)的科研合作伙伴!
如果您受時(shí)間、試驗(yàn)條件等限制而無(wú)法完成您的課題研究，歡迎您與我們聯(lián)系。
實(shí)驗(yàn)技術(shù)服務(wù)：
